BANK VONTOBEL/PUT/SANOFI/68/0.1/20.09.24 Share Price

Warrant

DE000VM4Q8X8

Market Closed - Deutsche Boerse AG 18:53:05 05/07/2024 BST
0.017 EUR -5.56% Intraday chart for BANK VONTOBEL/PUT/SANOFI/68/0.1/20.09.24
Current month-5.56%
1 month-5.56%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart SANOFI
Chart BANK VONTOBEL/PUT/SANOFI/68/0.1/20.09.24
Date Price Change
05/07/24 0.017 -5.56%
04/07/24 0.018 -5.26%
03/07/24 0.019 +11.76%
02/07/24 0.017 +13.33%
01/07/24 0.015 -16.67%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 06:53 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM4Q8X
ISINDE000VM4Q8X8
Date issued 27/10/2023
Strike 68
Maturity 20/09/2024 (76 Days)
Parity 10 : 1
Emission price 0.22
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.015
Delta-0.03x
Omega 13.98
Premium25.47x
Gearing413.36x
Moneyness 0.7477
Difference Strike -22.94
Difference Strike %-33.74%
Spread 0.01
Spread %37.04%
Intrinsic value 0.000000

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
90.94 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.86%
Consensus